Colony Group’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$2.04M Buy
155,097
+550
+0.4% +$7.21K 0.03% 327
2023
Q2
$1.95M Buy
154,547
+406
+0.3% +$4.93K 0.03% 348
2023
Q1
$2.01M Buy
154,141
+40,111
+35% +$650K 0.03% 344
2022
Q4
$2.01M Sell
114,030
-34,973
-23% -$586K 0.03% 377
2022
Q3
$2.27M Buy
149,003
+69,107
+86% +$1.12M 0.04% 316
2022
Q2
$1.19M Buy
+79,896
New +$1.49M 0.02% 417

Other funds holding MDRX

Colony Group's MDRX Position: Q3 2023 in Review

Colony Group increased its Veradigm Inc. Common Stock (MDRX) stake by 0.36% in Q3 2023, buying an estimated $7.21K and bringing the position to 155,097 shares worth $2.04M. The position accounts for 0.03% of the portfolio, ranked #327.

Colony Group first reported a position in MDRX in Q2 2022 and has held it in 6 quarters since. The position peaked at $2.27M in Q3 2022. 216 funds tracked by Wall St. Rank hold MDRX as of Q3 2023.

  • Colony Group held 155,097 shares of Veradigm Inc. Common Stock worth $2.04M as of Q3 2023.
  • Colony Group bought 550 Veradigm Inc. Common Stock shares in Q3 2023, an estimated $7.21K.
  • Veradigm Inc. Common Stock made up 0.03% of Colony Group's portfolio in Q3 2023, its #327 holding.
  • Colony Group first reported a position in Veradigm Inc. Common Stock in Q2 2022 and has held it in 6 quarters since.
  • Colony Group's Veradigm Inc. Common Stock position peaked at $2.27M in Q3 2022.
  • 216 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q3 2023.

Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.